Education
About Us
Working with TipRanks
Follow Us
Karyopharm Therapeutics INC (CH:KPTI)
:KPTI
KPTI Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
KPTI Stock 12 Month Forecast
There Are No Analyst Ratings for CH:KPTI In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
KPTI Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
CHF11.96
Buy
―
Upgraded
10/13/25
Leerink Partners
CHF6.38→CHF4.78
Hold
―
Reiterated
10/10/25
Robert W. Baird
CHF19.93→CHF16.74
Buy
―
Reiterated
10/09/25
Piper Sandler
CHF11.96→CHF9.57
Buy
―
Reiterated
10/09/25
RBC Capital
―
Buy
―
Reiterated
10/08/25
Barclays
CHF7.97
Buy
―
Reiterated
08/12/25
Raymond James
CHF59.79
Buy
―
Assigned
01/27/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
CHF11.96
Buy
―
Upgraded
10/13/25
Leerink Partners
CHF6.38→CHF4.78
Hold
―
Reiterated
10/10/25
Robert W. Baird
CHF19.93→CHF16.74
Buy
―
Reiterated
10/09/25
Piper Sandler
CHF11.96→CHF9.57
Buy
―
Reiterated
10/09/25
RBC Capital
―
Buy
―
Reiterated
10/08/25
Barclays
CHF7.97
Buy
―
Reiterated
08/12/25
Raymond James
CHF59.79
Buy
―
Assigned
01/27/25
Best Analysts Covering Karyopharm Therapeutics
1 Month
xxx
Success Rate
11/34 ratings generated profit
Average Return
-3.97%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 32.35% of your transactions generating a profit, with an average return of -3.97% per trade.
3 Months
xxx
Success Rate
6/18 ratings generated profit
Average Return
-13.36%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -13.36% per trade.
1 Year
Success Rate
3/18 ratings generated profit
Average Return
-38.08%
reiterated a buy rating 2 months ago
Copying Peter Lawson's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -38.08% per trade.
2 Years
xxx
Success Rate
2/18 ratings generated profit
Average Return
-56.11%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 11.11% of your transactions generating a profit, with an average return of -56.11% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
KPTI Analyst Recommendation Trends
Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
4
5
5
5
6
Buy
0
0
0
0
1
Hold
3
11
13
16
12
Sell
4
2
1
0
0
Strong Sell
0
0
0
0
0
total
11
18
19
21
19
Each month's total comprises the sum of three months' worth of ratings.
KPTI Stock Forecast FAQ
What is CH:KPTI’s average 12-month price target, according to analysts?
Currently, no data Available
What is CH:KPTI’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:KPTI, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Karyopharm Therapeutics INC a Buy, Sell or Hold?
Currently, no data Available
What is Karyopharm Therapeutics INC’s share price target?
Currently, no data Available
What do analysts say about Karyopharm Therapeutics INC?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Karyopharm Therapeutics INC?
To buy shares of CH:KPTI, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.